Prime Therapeutics Reports Modest Drug Trend Increases

Prime Therapeutics LLC’s 2019 drug trend report showed single-digit increases for its commercial and Medicare Part D lines of business. Medicaid trend increased 10.2%, with utilization of specialty drugs remaining the largest driver of trend. In all lines of business, utilization of traditional drugs increased at a typical rate of 0.5% to 2.7%. Meanwhile, as brand drugs continued transitioning to generics in both government programs, the unit cost of specialty drugs went down.

© 2023 MMIT
Jinghong Chen

Jinghong Chen Reporter

Jinghong produces infographics and data stories on health insurance and specialty pharmacy for AIS Health. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting. Before joining AIS in 2018, she worked at WBEZ, Al Jazeera English and The New York Times Chinese.

Related Posts

bills-and-pills
January 26

Medicare Enrollees May Still Face Affordability Issues After Part D Benefit Redesign

READ MORE
pills-in-hand
January 26

ICER Report Aims to Nudge Payers Toward Fairer Drug Coverage Policies

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
January 26

News Briefs: Lilly Alzheimer’s Drug Fails to Win Accelerated Approval

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today